4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052781
Chief Medical Officer sold 25,000 shares at $50.00 ($1,250,000)
- Chief Medical Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BALDO LANCE · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-29 | Exercise or conversion : show line 1 in the form | +25,000 | $7.80 | $195,000 | 25,000 | D |
| 2020-09-29 | Sale : show line 2 in the form | −25,000 | $50.00 | $1,250,000 | 0 | D |
| Open-market sales · 25,000 sh · avg $50.00 · $1,250,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-29 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −25,000 | 400,000 | D |
Loading xslF345X03/doc4.xml…